Incorporation of additional QC during subject sample analysis. [Bioanalytics]

posted by shreyas goswami  – India, 2024-03-13 10:30 (435 d 22:19 ago) – Posting: # 23907
Views: 2,788

Dear Divyen Shah,

Thanks for the response:-)

Is it acceptable to incorporate additional QC on the basis of AVG Cmax of analyzed subjects. or it should be evaluated by the concentration data of each period separately?????

Regards,
Shreyas Goswami

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,679 registered users;
96 visitors (0 registered, 96 guests [including 31 identified bots]).
Forum time: 09:49 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5